A Controlled Study of the Safety and Immunogenicity of ChimeriVax Japanese Encephalitis Vaccine in Thai Toddlers and Children

Trial Profile

A Controlled Study of the Safety and Immunogenicity of ChimeriVax Japanese Encephalitis Vaccine in Thai Toddlers and Children

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Japanese encephalitis vaccine (Primary) ; Hepatitis A vaccine inactivated
  • Indications Hepatitis A; Japanese encephalitis
  • Focus Adverse reactions
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 04 Nov 2016 Results of a 5-year follow-up assessment published in the Vaccine.
    • 26 Sep 2016 Results assessing immune response after a long term follow-up upto five years published in the Vaccine.
    • 06 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top